CSGALNACT2P2

Across TCGA pan-cancer cohorts, CSGALNACT2P2 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated CSGALNACT2P2 data layer compared with 1 for mutation status.

The strongest signal is observed in uveal melanoma (UVM), where higher CSGALNACT2P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CSGALNACT2P2 expression acts as an unfavorable survival marker.

UVM, READ, and KICH are the cancer types where CSGALNACT2P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	II,III,IV	0.213	0.718	.002	81	view →
READ	OS	Tertile	All	0.166	0.830	<.001	60	view →
KICH	OS	Tertile	II,III,IV	0.155	0.827	<.001	39	view →
KIRC	DFS	Tertile	IV	0.217	0.603	.013	18	view →
MESO	OS	Tertile	II,III,IV	0.181	0.577	.005	18	view →
ACC	OS	Tertile	All	0.147	0.685	.018	18	view →
PRAD	DFS	Tertile	All	0.829	0.939	.006	18	view →
ESCA	DFS	Tertile	II,III,IV	0.133	0.832	.024	9	view →
LUSC	DFS	Tertile	II,III,IV	0.220	0.681	.011	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

CSGALNACT2P2–UVM (OS)

Open the UVM breakdown →